Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-12-12Clinical Trial Update: Efficacy of Combined Treatment With CoQ10 and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder [NA]
This document provides an update on a clinical trial evaluating the efficacy of combining CoQ10 with methylphenidate in children with ADHD.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Internet-based Coaching for Young Adults With Neuropsychiatric Disorders [NA]
A completed clinical trial assessing internet-based coaching for young adults with neuropsychiatric disorders, including ADHD, autism spectr…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder [Phase 4]
Phase 4 trial comparing Vyvanse to Concerta in adolescents with ADHD completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Parent Training for Attention Deficit Hyperactivity Disorder (ADHD) Preschoolers [NA]
This clinical trial update reports that a parent-training program for preschoolers with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Gene-environment Interactions and Brain Functional Connectivity in Attention Deficit Hyperactivity Disorder [NA]
Completed clinical study exploring gene-environment interactions and brain functional connectivity in Attention Deficit Hyperactivity Disord…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-19FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Intuniv (guanfacine) from Takeda Pharmaceuticals America, expanding the labeling for its use…
-
CLINICAL_TRIALS research · 2014-11-18Clinical Trial Update: Methylphenidate on Intracortical Inhibition in Methamphetamine Abusers Attention Deficit Hyperactivity Disorder (ADHD) [NA]
This clinical trial update evaluates methylphenidate's effects on intracortical inhibition in individuals with ADHD who abuse methamphetamin…
-
FDA approval · 2014-11-10FDA Approved: GUANFACINE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s supplemental application for guanfacine, enabling the generic product to enter the market.
-
FDA approval · 2014-11-03FDA Approved: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for a generic fixed-dose combination of dextroamphetamine and amphetamine salts manufactured by Epic…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder [Phase 4]
Phase 4 clinical trial update reporting on the efficacy and safety of KAPVAY Extended-Release in children and adolescents with attention-def…
-
FDA approval · 2014-10-15FDA Approved: METHYLPHENIDATE HYDROCHLORIDE (LA) — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved an original application for methylphenidate hydrochloride (long-acting) generic product by Teva Pharmaceuticals USA, Inc. for t…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: Impact of CES1 Genotype on Metabolism of Methylphenidate [Phase 4]
Phase 4 trial investigating how CES1 genotype affects methylphenidate metabolism, with study status completed.
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: A Phase II, Adaptive Trial Design Examining the Pharmacokinetic and Pharmacodynamic Effects of Modified Release Amphetamine (HLD100, Formulations B, C and E)) in Adolescents and Children With Attention-Deficit Hyperactivity Disorder (ADHD) [Phase 1, Phase 2]
A Phase I/II adaptive trial evaluating the pharmacokinetic and pharmacodynamic effects of the extended-release amphetamine HLD100 formulatio…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants [Phase 4]
Phase 4 post-marketing study evaluating long-term efficacy and safety of osmotic-release methylphenidate in ADHD participants; results poste…
-
FDA approval · 2014-09-15FDA Approved: METHYLIN — Supplemental Application (SHIONOGI INC.)
FDA approved a supplemental application for METHYLIN (methylphenidate hydrochloride) submitted by Shionogi Inc.
-
FDA approval · 2014-09-12FDA Approved: EVEKEO — Supplemental Application (Azurity Pharmaceuticals, Inc.)
The FDA approved a supplemental application for EVEKEO (amphetamine sulfate) from Azurity Pharmaceuticals, Inc., resulting in an updated lab…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Blue Wavelength Light-blocking Glasses in ADHD-Insomnia [NA]
A completed clinical trial evaluated blue wavelength light-blocking glasses for ADHD with insomnia and delayed sleep phase symptoms; results…
-
CLINICAL_TRIALS trial_result · 2014-09-10Clinical Trial Update: Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein [EARLY_Phase 1]
This early-phase Phase 1 trial reports results on whether modifying dietary protein can improve neurocognitive and neurobiological measures …
-
CLINICAL_TRIALS research · 2014-09-09Clinical Trial Update: GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs [NA]
A completed qualitative trial evaluating game-based interactives in special education programs for ADHD and autism spectrum disorders.
-
CLINICAL_TRIALS trial_result · 2014-09-05Clinical Trial Update: Vascular Effects of Attention Deficit Hyperactivity Disorder (ADHD) Medications in Youth
This clinical trial update notes that the study evaluating vascular effects of ADHD medications in youth has been completed.
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence [Phase 2, Phase 3]
Clinical trials evaluated Adderall-XR for adult ADHD with cocaine dependence; study completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-29Clinical Trial Update: Dose Finding Study in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)(174007/P05805/MK-8777-003) [Phase 2]
Phase 2 dose-finding study in adults with Attention-Deficit/Hyperactivity Disorder completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Treatment Drop-out and Missed Appointments Among Adults With ADHD
This completed clinical trial update reports on treatment drop-out and missed appointments among adults with Attention-Deficit/hyperactivity…
-
FDA approval · 2014-08-22FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Supplemental Application (Par Health USA, LLC)
The FDA approved a supplemental application for dexmethylphenidate hydrochloride extended-release, confirming regulatory approval for this e…
-
CLINICAL_TRIALS trial_result · 2014-08-20Clinical Trial Update: Integrative Coping Group for Children [NA]
Duke University completed a clinical trial evaluating an Integrative Coping Group for Children for childhood depression and anxiety, with da…